Prostaglandin E2 modulates dendritic cell function via EP 2 and EP4 receptor subtypes

Journal of Leukocyte Biology

Volumn 73, Issue 6, 2003, Pages 756-763

  Harizi, Hedi ^a   Grosset, Christophe ^a   Gualde, Norbert ^a  

^a CNRS   (France)

Author keywords

Agonists; Cytokines; EP receptors; PGE2

Indexed keywords

17 PHENYL OMEGA TRINORPROSTAGLANDIN E2; ALCOHOL; BUCLADESINE; BUTAPROST; CYCLOOXYGENASE 2 INHIBITOR; INTERLEUKIN 10; LEUKOTRIENE B4; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E2 DERIVATIVE; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROSTANOID RECEPTOR; RECEPTOR SUBTYPE; SULPROSTONE; UNCLASSIFIED DRUG; CYTOKINE; EP4 RECEPTOR; HLA ANTIGEN CLASS 2; PROSTAGLANDIN EP2 RECEPTOR; PROSTAGLANDIN EP3 RECEPTOR; PROSTANOID RECEPTOR EP1;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL FUNCTION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFECT; DRUG SELECTIVITY; FLOW CYTOMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; FEMALE; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; METABOLISM; MIXED LYMPHOCYTE CULTURE; PHYSIOLOGY;

ANIMALIA;

ANIMALS; BUCLADESINE; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DINOPROSTONE; FEMALE; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED C57BL; RECEPTORS, PROSTAGLANDIN E;

EID: 0037666202     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1002483     Document Type: Article

References (52)

1. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, P., Plucka, K. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
2. Humes, J. L., Bonney, R. J., Pelus, L., Dahlgren, M. E., Sadowski, S. J., Kuehl Jr., F. A. (1977) Macrophage synthesis and release of prostaglandins in response to inflammatory stimuli. Nature 269, 149-151.
3. Nathan, C. F. (1987) Secretory products of macrophages. J. Clin. Invest. 79, 319-327.
4. 2 that contributes to the immunomodulation induced by antigen-presenting cells. Cell. Immunol. 209, 19-28.
5. Harizi, H., Gualde, N. (2002) Dendritic cells produce eicosanoids, which modulate generation and functions of antigen-presenting cells. Prostaglandins Leukot. Essent. Fatty Acids 66, 459-466.
6. Smith, W. L., Marnett, L. J., Dewitt, D. L. (1991) Prostaglandin and thromboxane biosynthesis. Pharmacol. Ther. 49, 153-179.
7. Dewitt, D. L. (1991) Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim. Biophys. Acta 1083, 121-134.
8. Funk, C. D., Funk, L. B., Kenuedy, M. E., Pong, A. S., FitzGerald, G. A. (1991) Human platelet/erhytroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J. 5, 2304-2312.
9. Hershman, H. (1996) Prostaglandin synthase 2. Biochim. Biophys. Acta 1299, 125-140.
10. Aderen, A. A., Cohen, D. S., Wright, S. D., Cohen, Z. A. (1986) Bacterial lipopolysaccharides prime macrophages for enhance release of arachidonic acid metabolites. J. Exp. Med. 164, 165-179.
11. Halushka, P. V., Mais, D. V., Mayeux, R. P., Morinelli, T. A. (1989) Thromboxane, prostaglandin, and leukotriene receptors. Annu. Rev. Pharmacol. Toxicol. 29, 213-239.
12. Coleman, R. A., Kennedy, I., Humphrey, P. P. A., Bunce, K., Lumpley, P. (1990) Prostanoids and their receptors. In Comprehensive Medicinal Chemistry, vol. 3 (C. Hansch, P. G. Sammes, J. B. Taylorand, J. C. Emmett, eds.), Oxford, Pergamon, 643.
13. Coleman, R. A., Smith, W. L., Narumiya, S. (1994) International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes, Pharmacol. Rev. 46, 205-229.
14. Negishi, M., Sugimoto, Y., Ichikawa, A. (1995) Molecular mechanism of diverse actions of prostanoid receptors. Biochim. Biophys. Acta 1259, 109-119.
15. Ichikawa, A., Sugimoto, Y., Negishi, M. (1996) Molecular aspects of the structures and functions of the E prostanoid receptors. J. Lipid Mediat. Cell Signal. 14, 83-87.
16. Walabe, A., Sugimoto, Y., Honda, A., Irie, A., Namba, T., Negushi, M., Ito, S., Narumiya, S., Ichikawa, A. (1993) Cloning and expression of cDNA for a mouse EP receptors for prostaglandin E. J. Biol. Chem. 268, 20175-20178.
17. Coleman, R. A., Eglen, R. M., Jones, R. L., Narumiya, S., Shinfizu, T., Smith, W. L., Dahlen, S. E. M., Drazen, J. M., Gardinet, P. J., Jackson, W. T., Jones, T. R., Krell, D. R., Nicosia, S. (1995) Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature. Adv. Prostaglandin Thromboxane Leukot. Res. 23, 283-285.
18. 2 subtype: cloning, expression, and northern blot analysis. FEBS Lett. 372, 151-156.
19. Tilley, S. L., Coffman, T. M., Koller, B. H. (2001) Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108, 15-23.
20. 2 that regulate cellular immune responses in the mouse. J. Clin. Invest. 108, 1229-1235.
21. 2 enhances the production of endogenous IL-10, which down-regulates dendritic cell function. J. Immunol. 168, 2255-2263.
22. Kambayashi, T., Wallin, R. P. A., Ljunggen, H-H. (2001) cAMP-elevating agents suppress dendritic cell function. J. Leukoc. Biol. 70, 903-910.
23. Gualde, N., Wheiberger, O., Ratnofsky, S., Benacerraf, B., Burakoff, S. J. (1982) In vitro generation of helper cells. and suppressor T cells that regulate cytotolytic T lymphocyte response to trinitrophenyl modified syngeneic cells. Transplantation 33, 422-431.
24. 2 receptor on normal and malignant murine B lymphocytes. Cell. Immunol. 161, 79-87.
25. 4. Mol. Immunol. 33, 33-45.
26. Snyder, D., Beller, D., Unanue, E. (1982) Prostaglandins modulate macrophage la expression. Nature 299, 163-166.
27. 2 blocks inflammation, hyperalgesia, and interleukin-6 production in vivo. J. Exp. Med. 184, 883-891.
28. 4 enhances interleukin-6 production and IL-6 messenger accumulation in human monocytes in vitro: transcriptional and posttranscriptional mechanisms. Blood 80, 1004-1111.
29. 2 suppresses TNF-α, but not inlerleukin-1α or β mRNA and cell associated bioactivity. J. Leukoc. Biol. 45, 416-421.
30. 4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc. Natl. Acad. Sci. USA 93, 10978-10983.
31. Rappaport, R. S., Dodge, G. R. (1982) Prostaglandin E inhibits the production of human interleukin-2. J. Exp. Med. 155, 943-948.
32. Goodwin, J. S., Bankhurst, A. D., Messner, R. P. (1977) Suppression of human T cell mitogenesis by prostaglandins. Existence of prostaglandin-producing suppressor T cells. J. Exp. Med. 146, 1719-1734.
33. 2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin production and down-regulation of Transferring receptor expression. J. Immunol. 135, 1172-1179.
34. Hasler, F., Bluestein, H. G., Zvaiflev, N. J., Epstein, L. B. (1983) Analysis of the effect responsible for the impaired regulation of the EBV-induced B cell proliferation by rheumatoid arthritis lymphocytes. Role of monocytes and increased sensitivity of rheumatoid arthritis lymphocytes to prostaglandin. J. Immunol. 131, 768-772.
35. 2 regulates the migratory capacity of specific DC subsets. Blood 100, 1362-1372.
36. 2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100, 1354-1361.
37. + dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 161, 2804-2809,
38. Jonuleit, H., Kuhn, U., Muller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J., Enk, A. H. (1997) Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27, 3135-3142.
39. 2 type response in BALB/c mice. J. Immunol. 164, 2386-2395.
40. 2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J. Exp. Med. 193, 1135-1147.
41. 2 and non-steroidal anti-inflammatory drugs. Biochem. Biophys. Res. Commun. 278, 790-796.
42. 4 and their different regulation by lipopolysaccharide in CH3/HeN peritoneal macrophages. J. Immunol. 166, 4689-4696.
43. 2 receptor subtypes in M-1 mouse CCD cells. Am. J. Physiol. Renal Physiol. 281, F123-F132.
44. Narumiya, S. (1996) Prostanoid receptors and signal transduction. Prog. Brain Res. 113, 231-241.
45. 2 receptors. Proc. Natl. Acad. Sci. USA 95, 15792-15797.
46. 4 in the nuclear envelope. J. Biol. Chem. 274, 15719-15724.
47. 2 stimulates IL-8 gene expression in human colonic, epithelial cells by a posttranscriptional mechanism. J. Immunol. 161, 3746-3752.
48. 2 inhibits lipopolysaccharide-induced TNFα generation. Br. J. Pharmacol. 122, 149-157.
49. 2 subtype. J. Biol. Chem. 268, 7759-7762.
50. Walterscheid, J. P., Ullrich, S. E., Nghiem, D. X. (2002) Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J. Exp. Med. 195, 171-179.
51. 4 production from dendritic cells via an IL-10-dependent mechanism. J. Immunol. 170, 139-146.
52. Platzer, C., Fritsch, E., Elsner, T., Lehman, M. H., Volk, H-D., Prosch, S. (1999) cAMP-responsive elements are involved in the transcriptional activation of human IL-10 gene in monocytic cells. Eur. J. Immunol. 29, 3098-3104.